INVO Fertility (IVF) Competitors

$1.60 +0.04 (+2.24%)

Closing price 05/15/2026 03:56 PM Eastern

Extended Trading

$1.63 +0.04 (+2.32%)

As of 05/15/2026 07:56 PM Eastern

IVF vs. SINT, LFWD, VVOS, TNON, and NXL

Should you buy INVO Fertility stock or one of its competitors? MarketBeat compares INVO Fertility with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with INVO Fertility include Sintx Technologies (SINT), Lifeward (LFWD), Vivos Therapeutics (VVOS), Tenon Medical (TNON), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.

How does INVO Fertility compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Sintx Technologies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.31, meaning that its stock price is 131% more volatile than the broader market.

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Comparatively, 0.7% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sintx Technologies currently has a consensus price target of $11.00, suggesting a potential upside of 384.58%. INVO Fertility has a consensus price target of $20.00, suggesting a potential upside of 1,153.92%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

INVO Fertility has a net margin of -417.02% compared to Sintx Technologies' net margin of -1,018.08%. INVO Fertility's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,018.08%	-242.76%	-99.86%
INVO Fertility	-417.02%	N/A	-92.42%

INVO Fertility has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	9.17	-$10.36M	-$5.66	N/A
INVO Fertility	$6.53M	0.40	-$9.10M	-$3.15 thousand	N/A

In the previous week, Sintx Technologies had 1 more articles in the media than INVO Fertility. MarketBeat recorded 2 mentions for Sintx Technologies and 1 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 1.89 beat Sintx Technologies' score of -0.57 indicating that INVO Fertility is being referred to more favorably in the news media.

Company	Overall Sentiment
Sintx Technologies	Negative
INVO Fertility	Very Positive

Summary

INVO Fertility beats Sintx Technologies on 11 of the 17 factors compared between the two stocks.

How does INVO Fertility compare to Lifeward?

INVO Fertility (NASDAQ:IVF) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

INVO Fertility has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market.

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 1,153.92%. Lifeward has a consensus price target of $10.00, indicating a potential upside of 49.25%. Given INVO Fertility's stronger consensus rating and higher probable upside, equities research analysts clearly believe INVO Fertility is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Lifeward	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Lifeward has a net margin of -90.38% compared to INVO Fertility's net margin of -417.02%. INVO Fertility's return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Lifeward	-90.38%	-145.55%	-78.36%

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 0.7% of INVO Fertility shares are held by company insiders. Comparatively, 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

INVO Fertility has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53M	0.40	-$9.10M	-$3.15 thousand	N/A
Lifeward	$22.03M	0.46	-$19.91M	-$19.66	N/A

In the previous week, Lifeward had 7 more articles in the media than INVO Fertility. MarketBeat recorded 8 mentions for Lifeward and 1 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 1.89 beat Lifeward's score of -0.14 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Overall Sentiment
INVO Fertility	Very Positive
Lifeward	Neutral

Summary

Lifeward beats INVO Fertility on 9 of the 17 factors compared between the two stocks.

How does INVO Fertility compare to Vivos Therapeutics?

INVO Fertility (NASDAQ:IVF) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

INVO Fertility has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market. Comparatively, Vivos Therapeutics has a beta of 6.25, meaning that its share price is 525% more volatile than the broader market.

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 1,153.92%. Vivos Therapeutics has a consensus price target of $2.58, indicating a potential upside of 303.02%. Given INVO Fertility's stronger consensus rating and higher probable upside, equities research analysts clearly believe INVO Fertility is more favorable than Vivos Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Vivos Therapeutics	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Vivos Therapeutics has a net margin of -121.37% compared to INVO Fertility's net margin of -417.02%. INVO Fertility's return on equity of 0.00% beat Vivos Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Vivos Therapeutics	-121.37%	-849.22%	-96.11%

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 0.7% of INVO Fertility shares are held by company insiders. Comparatively, 2.1% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

INVO Fertility has higher earnings, but lower revenue than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53M	0.40	-$9.10M	-$3.15 thousand	N/A
Vivos Therapeutics	$17.44M	0.50	-$21.17M	-$2.07	N/A

In the previous week, Vivos Therapeutics had 3 more articles in the media than INVO Fertility. MarketBeat recorded 4 mentions for Vivos Therapeutics and 1 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 1.89 beat Vivos Therapeutics' score of 0.58 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Overall Sentiment
INVO Fertility	Very Positive
Vivos Therapeutics	Positive

Summary

Vivos Therapeutics beats INVO Fertility on 9 of the 17 factors compared between the two stocks.

How does INVO Fertility compare to Tenon Medical?

INVO Fertility (NASDAQ:IVF) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

INVO Fertility has a beta of 2.31, meaning that its stock price is 131% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market.

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 0.7% of INVO Fertility shares are held by insiders. Comparatively, 0.3% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Tenon Medical has a net margin of -270.09% compared to INVO Fertility's net margin of -417.02%. INVO Fertility's return on equity of 0.00% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Tenon Medical	-270.09%	-560.04%	-115.53%

INVO Fertility has higher revenue and earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53M	0.40	-$9.10M	-$3.15 thousand	N/A
Tenon Medical	$3.94M	2.03	-$12.56M	-$1.29	N/A

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 1,153.92%. Given INVO Fertility's stronger consensus rating and higher probable upside, research analysts clearly believe INVO Fertility is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tenon Medical had 5 more articles in the media than INVO Fertility. MarketBeat recorded 6 mentions for Tenon Medical and 1 mentions for INVO Fertility. INVO Fertility's average media sentiment score of 1.89 beat Tenon Medical's score of -0.04 indicating that INVO Fertility is being referred to more favorably in the media.

Company	Overall Sentiment
INVO Fertility	Very Positive
Tenon Medical	Neutral

Summary

INVO Fertility beats Tenon Medical on 11 of the 17 factors compared between the two stocks.

How does INVO Fertility compare to Nexalin Technology?

INVO Fertility (NASDAQ:IVF) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Nexalin Technology has lower revenue, but higher earnings than INVO Fertility. Nexalin Technology is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53M	0.40	-$9.10M	-$3.15 thousand	N/A
Nexalin Technology	$300K	23.50	-$8.22M	-$0.47	N/A

INVO Fertility has a beta of 2.31, meaning that its share price is 131% more volatile than the broader market. Comparatively, Nexalin Technology has a beta of 3.56, meaning that its share price is 256% more volatile than the broader market.

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 0.7% of INVO Fertility shares are owned by insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

INVO Fertility has a net margin of -417.02% compared to Nexalin Technology's net margin of -3,018.12%. INVO Fertility's return on equity of 0.00% beat Nexalin Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

In the previous week, INVO Fertility and INVO Fertility both had 1 articles in the media. INVO Fertility's average media sentiment score of 1.89 equaled Nexalin Technology'saverage media sentiment score.

Company	Overall Sentiment
INVO Fertility	Very Positive
Nexalin Technology	Very Positive

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 1,153.92%. Given INVO Fertility's stronger consensus rating and higher possible upside, equities analysts plainly believe INVO Fertility is more favorable than Nexalin Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

INVO Fertility beats Nexalin Technology on 9 of the 14 factors compared between the two stocks.

Get INVO Fertility News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IVF vs. The Competition

Export

Metric	INVO Fertility	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.58M	$52.48M	$6.38B	$12.30B
Dividend Yield	N/A	1.08%	2.81%	5.27%
P/E Ratio	0.00	16.78	20.66	25.27
Price / Sales	0.40	39.04	552.35	74.70
Price / Cash	N/A	18.87	42.43	54.86
Price / Book	0.00	15.72	9.87	6.90
Net Income	-$9.10M	-$16.63M	$3.57B	$334.66M
7 Day Performance	-7.27%	-4.70%	0.23%	0.12%
1 Month Performance	-24.05%	-13.55%	-2.54%	-0.18%
1 Year Performance	-99.33%	-8.84%	33.54%	30.62%

INVO Fertility Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IVF INVO Fertility	2.0562 of 5 stars	$1.60 +2.2%	$20.00 +1,153.9%	-99.3%	$2.58M	$6.53M	N/A	10
SINT Sintx Technologies	3.0328 of 5 stars	$2.40 -3.2%	$11.00 +358.3%	-28.2%	$10.22M	$1.02M	N/A	40	Earnings Report
LFWD Lifeward	1.8387 of 5 stars	$6.48 +1.3%	$10.00 +54.3%	-57.1%	$9.78M	$22.03M	N/A	60	News Coverage Earnings Report
VVOS Vivos Therapeutics	3.0914 of 5 stars	$0.73 +4.9%	$2.58 +255.7%	-74.8%	$9.50M	$17.44M	N/A	160	News Coverage Upcoming Earnings
TNON Tenon Medical	0.7903 of 5 stars	$0.81 +3.0%	N/A	-36.3%	$8.92M	$3.94M	N/A	8	News Coverage Earnings Report Analyst Forecast High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IVF) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

INVO Fertility (IVF) Competitors

IVF vs. SINT, LFWD, VVOS, TNON, and NXL

How does INVO Fertility compare to Sintx Technologies?

Summary

How does INVO Fertility compare to Lifeward?

Summary

How does INVO Fertility compare to Vivos Therapeutics?

Summary

How does INVO Fertility compare to Tenon Medical?

Summary

How does INVO Fertility compare to Nexalin Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IVF vs. The Competition

INVO Fertility Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

INVO Fertility (IVF) Competitors

IVF vs. SINT, LFWD, VVOS, TNON, and NXL

How does INVO Fertility compare to Sintx Technologies?

Which has more volatility and risk, SINT or IVF?

Do insiders & institutionals hold more shares of SINT or IVF?

Do analysts recommend SINT or IVF?

Is SINT or IVF more profitable?

Which has better earnings & valuation, SINT or IVF?

Does the media prefer SINT or IVF?

Summary

How does INVO Fertility compare to Lifeward?

Which has more risk and volatility, IVF or LFWD?

Do analysts rate IVF or LFWD?

Is IVF or LFWD more profitable?

Do insiders and institutionals hold more shares of IVF or LFWD?

Which has higher valuation and earnings, IVF or LFWD?

Does the media refer more to IVF or LFWD?

Summary

How does INVO Fertility compare to Vivos Therapeutics?

Which has more risk and volatility, IVF or VVOS?

Do analysts rate IVF or VVOS?

Is IVF or VVOS more profitable?

Do insiders and institutionals hold more shares of IVF or VVOS?

Which has higher valuation and earnings, IVF or VVOS?

Does the media refer more to IVF or VVOS?

Summary

How does INVO Fertility compare to Tenon Medical?

Which has more volatility & risk, IVF or TNON?

Do institutionals and insiders hold more shares of IVF or TNON?

Is IVF or TNON more profitable?

Which has better earnings and valuation, IVF or TNON?

Do analysts rate IVF or TNON?

Does the media prefer IVF or TNON?

Summary

How does INVO Fertility compare to Nexalin Technology?

Which has preferable earnings & valuation, IVF or NXL?

Which has more risk & volatility, IVF or NXL?

Do insiders & institutionals believe in IVF or NXL?

Is IVF or NXL more profitable?

Does the media prefer IVF or NXL?

Do analysts recommend IVF or NXL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IVF vs. The Competition

INVO Fertility Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools